Assignee
MABWELL THERAPEUTICS INC
US·5 granted patents·6 pending applications·2 citations·filing 2021–2025
Top patents by PatentIndex Score
11 records- 0189US11866513B2Anti-TMPRSS6 antibodies and uses thereofMABWELL THERAPEUTICS INC·Filed 2023·Granted Jan 9, 2024·1 cites·25 claims
- 0284US12215170B2Anti-TMPRSS6 antibodies and uses thereofMABWELL THERAPEUTICS INC·Filed 2021·Granted Feb 4, 2025·1 cites·20 claims
- 0378US2024301046A1Anti-amyloid beta protofibril/oligomer antibodies and uses thereofMABWELL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0477US12084492B2Anti-amyloid beta protofibril/oligomer antibodies and uses thereofMABWELL THERAPEUTICS INC·Filed 2024·Granted Sep 10, 2024·0 cites·12 claims
- 0570US2024158483A1Anti-c1s antibodies and uses thereofMABWELL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0666US11958899B2Anti-C1s antibodies and uses thereofMABWELL THERAPEUTICS INC·Filed 2022·Granted Apr 16, 2024·0 cites·22 claims
- 0765US2025304719A1Anti-tmprss6 antibodies and uses thereofMABWELL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0861US2025136718A1Anti-tmprss6 antibodies and uses thereofMABWELL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0958US2026049157A1Anti-MuSK Agonistic AntibodiesMABWELL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1057US2023295345A1Anti-tmprss6 antibodies and uses thereofMABWELL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1152US12545729B2Anti-TREM2 agonist antibodies and antigen-binding fragments thereof that can increase levels of soluble TREM2 in serum and brain tissueMABWELL THERAPEUTICS INC·Filed 2025·Granted Feb 10, 2026·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when MABWELL THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →